Description: The fluorecare®️ Combination Test for SARS-CoV-2 & Influenza A/B Virus & RSV Antigens can be used for the simultaneous qualitative detection and differentiation of novel coronaviruses (SARS-CoV-2 antigens), influenza A virus antigens, influenza B virus antigens and/or RSV antigens in population-based nasal swab specimens in vitro.
Results in approx. 20 min.
CE approval: CE 2934
Specificity: 100,00%
Sensitivity: 92,93%
Content: 1 test kit per packaging unit (PU)
Prices net plus VAT.
Delivery time:
-Germany: immediately, ex warehouse Berlin; by courier (approx. 2-4 days)
- Austria & Switzerland: immediately, ex warehouse Berlin; by courier (approx. 3-4 days)